advertisement
Lines CR 1
Showing records 1 to 1 | Display all abstracts from Lines CR10139 Efficacy and tolerability of the dorzolamide 2%/timolol 0.5% combination (COSOPT) versus 0.005% (XALATAN) in the treatment of ocular hypertension or glaucoma: results from two randomized clinical trials
Fechtner RD; Airaksinen PJ; Getson AJ; Lines CR; Adamsons IA; COSOPT versus XALATAN Study Groups
Acta Ophthalmologica Scandinavica 2004; 82: 42-48
